help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 5, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1209
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
93/4/1497    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thamer, C.
Right arrow Articles by Haring, H.-U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thamer, C.
Right arrow Articles by Haring, H.-U.
Related Collections
Right arrow Metabolism

Submitted on May 31, 2007
Accepted on January 24, 2008

Variations in PPARD Determine the Change in Body Composition during Lifestyle Intervention: A Whole-Body Magnetic Resonance Study

Claus Thamer, Jürgen Machann, Norbert Stefan, Silke A. Schäfer, Fausto Machicao, Harald Staiger, Markku Laakso, Michael Böttcher, Claus Claussen, Fritz Schick, Andreas Fritsche, and Hans-Ulrich Haring*

Medical Clinic, Department of Endocrinology, Metabolism, Clinical Chemistry, Nephrology and Angiology, Eberhard-Karls-University, Tuebingen, Germany; Section on Experimental Radiology, Department of Diagnostic Radiology, Eberhard-Karls-University, Tübingen, Germany; University of Kuopio, KI-70210 Kuopio, Finland

* To whom correspondence should be addressed. E-mail: Hans-Ulrich.Haering{at}med.uni-tuebingen.de.

Context: We recently demonstrated that single nucleotide polymorphisms (SNPs) in the peroxisome proliferator-activated receptor {delta} gene (PPARD), i.e. rs1053049, rs6902123, and rs2267668, affect the improvement of mitochondrial function, aerobic physical fitness, and insulin sensitivity by lifestyle intervention (LI).

Objective: To determine whether the aforementioned PPARD SNPs influence the change in body composition and ectopic fat storage during LI.

Design: 156 subjects at an increased risk for type 2 diabetes were genotyped for rs1053049, rs6902123, and rs2267668 and participated in a LI program. Body fat depots, ectopic liver fat, and muscle volume of the leg were quantified using magnetic resonance spectroscopy and imaging.

Results: With regard to body composition, carriers of the minor SNP alleles displayed reduced responses to LI, i.e. LI-induced reduction in adipose tissue mass (non-visceral adipose tissue: rs1053049, p=0.02; rs2267668, p=0.04; visceral adipose tissue: rs1053049, p=0.0and in hepatic lipids (rs1053049, p=0.04; rs6902123, p=0.001; independent of changes in adiposity) as well as LI-induced increase in relative muscle volume of the leg (rs1053049, p=0.003; rs2267668 p=0.009) were less pronounced in homo- and heterozygous carriers of the minor alleles as compared to homozygous carriers of the major alleles.

Conclusion: SNPs rs1053049, rs6902123, and rs2267668 in PPARD affect LI-induced changes in overall adiposity, hepatic fat storage, and relative muscle mass. Our findings provide a mechanistic explanation for the involvement of these genetic variations in the development of insulin resistance and type 2 diabetes.


Key words: PPARD • Muscle Mass • Adiposity • Magnetic Resonance Imaging







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society